Adenosine signaling: Optimal target for gastric cancer immunotherapy

Adenosine signaling: Optimal target for gastric cancer immunotherapy

Gastric cancer (GC) is one of the most common malignancy and leading cause of cancer-related deaths worldwide. Due to asymptomatic or only nonspecific early symptoms, GC patients are usually in the advanced stage at first diagnosis and miss the best opportunity of treatment. Immunotherapies, especia...

Full description

Bibliographic Details
Main Authors: Junqing Wang, Linyong Du, Xiangjian Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
gastric cancer
CD39
CD73
adenosine
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1027838/full

Similar Items

Similar Items